<DOC>
	<DOCNO>NCT00569231</DOCNO>
	<brief_summary>The purpose study look people respond treatment wart use Candida antigen get immune response rid body human papillomavirus ( HPV ) . The immune system part body fights infection like HPV cause wart . This research study examine response wart inject portion common yeast ( candida ) study drug . Your immune system response also look test call ELISPOT assay . This test do blood sample . The result test may help u determine Candida antigen affect wart .</brief_summary>
	<brief_title>Study With Candida Antigen Treatment Warts</brief_title>
	<detailed_description>The use recall antigens treat wart yet Food Drug Administration ( FDA ) approve . The primary goal work assess safety Candin investigational new drug ( IND ) treatment wart . In addition , clinical resolution treat untreated wart evaluate immunologic response examine use ex vivo interferon-γ enzyme-linked immunospot ( IFN-γ ELISPOT ) assay order elucidate immunologic mechanism behind successful regression warts patient undergo Candin injection immunotherapy .</detailed_description>
	<mesh_term>Warts</mesh_term>
	<criteria>Subjects must age 1850 . Female subject childbearing potential must negative urine pregnancy test treatment . Female subject childbearing potential agree use reliable form birth control risk associate candida antigens pregnancy know . Subjects must two cutaneous , nongenital , nonfacial wart . Subjects must able provide write , informed consent . Subjects must willing comply requirement protocol . Subjects vital sign must within follow parameter time enrollment : Blood Pressure &lt; 150/95 mmHg Temperature &lt; 100.4° F Pulse Rate 50 100 beats/minute Respiratory Rate &lt; 24 breaths/minute Subjects history disease treatment cause subject immunosuppressed include , limited , cancer , HIV , organ transplantation . Immunosuppression determine medical history . Subjects pregnant , lactating , attempt become pregnant , risk associate candida antigen pregnancy know . Subjects genital facial wart . Subjects unable return followup visit comply protocol . Subjects know allergy Thimerosol candida antigen . Subjects history asthma determine medical history treatment asthmatic episode . Subjects type diabetes . Subjects currently use nonselective Beta Blockers . Subjects currently use H2 antagonist ( e.g. , cimetidine ) . There 24 hour washout period use H2 antagonists prior begin treatment study . Subjects history keloid formation . Subjects history alcohol illicit drug abuse , determine medical history . Subjects previous treatment candida antigens wart . Subjects currently use treatment wart . This include prescription overthecounter medication . Subjects must wash¬out period 30 day previous treatment prior begin study . Subjects blood pressure &gt; 150/95 , temperature &gt; 100.4° F , pulse rate &lt; 50 &gt; 100 beat per minute , respiratory rate &gt; 24 time enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Warts</keyword>
	<keyword>Candida</keyword>
	<keyword>HPV</keyword>
	<keyword>Injections , Intralesional</keyword>
	<keyword>Immune System</keyword>
</DOC>